Stockscreener 앱 받기
171.28
2.07%
3.47
시간 외 거래:
171.28
전일 마감가:
$167.81
열려 있는:
$169.95
하루 거래량:
1.61M
Relative Volume:
0.98
시가총액:
$28.59B
수익:
$16.63B
순이익/손실:
$1.39B
주가수익비율:
21.23
EPS:
8.0674
순현금흐름:
$2.12B
1주 성능:
-4.40%
1개월 성능:
+2.01%
6개월 성능:
-23.93%
1년 성능:
+10.38%
1일 변동 폭
$168.75
$172.84
1주일 범위
$162.22
$177.53
52주 변동 폭
$154.50
$247.04
아이큐비아 홀딩스 Stock (IQV) Company Profile
명칭
Iqvia Holdings Inc
전화
919-998-2000
주소
2400 ELLIS ROAD, DURHAM, NC
Compare IQV vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
171.28 | 28.00B | 16.63B | 1.39B | 2.12B | 8.0674 |
TMO
Thermo Fisher Scientific Inc
|
469.35 | 172.66B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
178.97 | 125.40B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
541.31 | 44.34B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
126.67 | 35.89B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
357.20 | 34.90B | 3.77B | 449.25M | 240.68M | 7.8556 |
아이큐비아 홀딩스 Stock (IQV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-09 | 업그레이드 | TD Cowen | Hold → Buy |
| 2026-03-06 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2026-03-03 | 개시 | RBC Capital Mkts | Outperform |
| 2025-12-02 | 재개 | Morgan Stanley | Overweight |
| 2025-11-13 | 개시 | BMO Capital Markets | Outperform |
| 2025-11-03 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-10-29 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-10-09 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2025-09-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-04-25 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-04-10 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-02-03 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-12-20 | 개시 | Stephens | Overweight |
| 2024-10-14 | 개시 | Redburn Atlantic | Buy |
| 2024-09-04 | 개시 | RBC Capital Mkts | Outperform |
| 2024-07-24 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-06-06 | 개시 | Goldman | Buy |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-02-15 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-02-13 | 개시 | BTIG Research | Buy |
| 2023-11-02 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-03-17 | 개시 | Truist | Buy |
| 2022-12-06 | 개시 | Cowen | Outperform |
| 2022-11-17 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-07-15 | 개시 | SVB Leerink | Outperform |
| 2022-05-24 | 개시 | Guggenheim | Buy |
| 2022-04-29 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-04-16 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2020-07-07 | 개시 | Stephens | Equal-Weight |
| 2020-03-02 | 개시 | Deutsche Bank | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-12-13 | 업그레이드 | CFRA | Sell → Hold |
| 2019-11-14 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | 업그레이드 | Mizuho | Neutral → Buy |
| 2019-05-28 | 개시 | SVB Leerink | Outperform |
| 2019-01-18 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-10-09 | 개시 | UBS | Buy |
| 2018-10-02 | 재확인 | Robert W. Baird | Outperform |
| 2018-07-25 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | 재확인 | Stifel | Buy |
| 2018-07-03 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-03-07 | 업그레이드 | SunTrust | Hold → Buy |
| 2018-01-19 | 개시 | Evercore ISI | Outperform |
모두보기
아이큐비아 홀딩스 주식(IQV)의 최신 뉴스
IQVIA Holdings trades in a tight range, technicals flag cautious signal for the shares - AD HOC NEWS
IQVIA Holdings Inc (IQV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Global Decentralized Clinical Trials Market Size/Share Worth USD 38.3 Billion by 2035 at a 14.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
IQVIA Holdings analyst views shift, shares trade below recent targets - AD HOC NEWS
IQVIA Holdings, Inc. (IQV): Investor Outlook On A 34% Potential Upside - DirectorsTalk Interviews
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MSN
IQVIA HoldingsAnalyst consensus and long-term drivers - AD HOC NEWS
Why IQVIA’s Orchestrated Customer Engagement quietly shapes pharma sales - AD HOC NEWS
IQVIA Holdings StockMorgan Stanley cuts rating and trims target - AD HOC NEWS
Morgan Stanley Maintains IQVIA Holdings(IQV.US) With Hold Rating, Raises Target Price to $225 - Moomoo
IQV News | IQVIA HOLDINGS INC (NYSE:IQV) - ChartMill
IQVIA Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
IQVIA Holdings Inc (IQV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IQVIA Holdings Inc (IQV) Valuation: PE, PB & Fair Value Analysis - TradingKey
IQVIA Holdings Inc (IQV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IQVIA Holdings Inc (IQV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IQVIA Holdings Inc (IQV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IQVIA Holdings Inc (IQV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Saratoga Health & Biotechnology Fund's IQVIA Holdings Inc(IQV) Holding History - GuruFocus
IQVIA Holdings Inc (IQV) Institutional Confidence - TradingKey
IQVIA Holdings Inc (IQV) Stock Price, Trades & News - GuruFocus
Is IQVIA Holdings Inc (IQV) a Bargain After 4.7% Drop? GF Value Says Undervalued - GuruFocus
IQVIA Holdings Inc (IQV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IQVIA Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Charles River upgraded, IQVIA downgraded as Morgan Stanley revisits CRO coverage - MSN
IQVIA Holdings, Inc. Stock 12‑Month Price Target Cut to $223.28, Implies 25% Upside - TradingView
IQV Downgraded by Morgan Stanley -- Price Target Lowered to $200 - GuruFocus
Why is IQVIA Holdings stock sliding today? By Investing.com - Investing.com Nigeria
Morgan Stanley Downgrades IQVIA Holdings to Equalweight From Overweight, Adjusts Price Target to $200 From $225 - marketscreener.com
Morgan Stanley downgrades IQVIA stock rating on margin concerns - Investing.com UK
Morgan Stanley Downgrades IQVIA Holdings(IQV.US) to Hold Rating, Cuts Target Price to $200 - Moomoo
(IQV) Risk Channels and Responsive Allocation - Stock Traders Daily
IQVIA Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
IQVIA Holdings Stock (US46266C1053): Analyst Views and Valuation Under the Microscope - AD HOC NEWS
Global Healthcare Infrastructure Strengthens IQV Amid Weak Liquidity - Yahoo Finance
Here's why IQVIA Holdings (IQV) is a strong momentum stock - MSN
Wiley and IQVIA Release Cross-Sector Report on AI’s Promise and Pressure Points Across Healthcare Value Chain - Financial Times
IQVIA Holdings, Inc. (IQV) Stock Analysis: Exploring a Potential 25% Upside in Healthcare Innovation - DirectorsTalk Interviews
IQV Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Is IQVIA Holdings stock outperforming the Dow? - MSN
IQVIA Is More Than a Contract Research Outsourcing Trade - AlphaStreet
IQVIA HOLDINGS INC CMNRo Khanna Congressional Trade on May. 27, 2026 - Quiver Quantitative
IQVIA Holdings Inc. Indenture and 8-K Filing Details for Notes Issuance (June 11, 2026) - Minichart
IQVIA Holdings Stock (US46266C1053): sector peers frame the valuation debate - AD HOC NEWS
IQVIA Holdings Inc. (IQV) Announces €950 Million Notes Offering - GuruFocus
IQVIA Raises €950 Million Via 4.625% Senior Notes Due 2033 to Refinance Debt - TradingView
€950M 4.625% 2033 notes support IQVIA (NYSE: IQV) debt refinancing - Stock Titan
IQVIA (IQV) Q1 2026 Earnings Call Transcript - AOL.com
IQVIA Holdings earnings preview: What to expect - MSN
IQVIA Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Q1 Earnings Roundup: IQVIA (NYSE:IQV) And The Rest Of The Drug Development Inputs & Services Segment - Yahoo Finance UK
아이큐비아 홀딩스 (IQV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.20%
0.64%
자본화:
|
볼륨(24시간):